drugset / Trial / NCT03687931
A Clinical Study to Assess the Efficacy and Safety of Dexamethasone Suspension for Cataract Surgery
RandomizedParallel-groupOpen-labelTreatment
Summary
Patients at least 40 years of age who are undergoing cataract surgery will be randomized to receive treatment with one of two dose levels of dexamethasone ophthalmic suspension eye drops to determine if the drops decrease inflammation inside the eye and are safe after cataract surgery.
Timeline
- Start
- 2018-08-26
- Primary completion
- 2019-02-28
- Completion
- 2019-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexamethasone | Small molecule | — | Other |